GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainCool AB (OSTO:BRAIN) » Definitions » Capital Expenditure

BrainCool AB (OSTO:BRAIN) Capital Expenditure : kr-8.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is BrainCool AB Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

BrainCool AB's cash flow for capital expenditures for the three months ended in Mar. 2024 was kr-3.77 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was kr-8.02 Mil.


BrainCool AB Capital Expenditure Historical Data

The historical data trend for BrainCool AB's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainCool AB Capital Expenditure Chart

BrainCool AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.12 -7.57 -10.82 -7.40 -6.07

BrainCool AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.82 -1.95 -1.27 -1.03 -3.77

BrainCool AB Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-8.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BrainCool AB (OSTO:BRAIN) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Lund, SWE, 22381
BrainCool AB is a medical device company engaged in developing, marketing, and selling medical cooling systems for diseases like stroke, oral mucositis, migraine, and sudden cardiac arrest.

BrainCool AB (OSTO:BRAIN) Headlines

No Headlines